CCCL [China Ceramics] 6-K: (Original Filing)

[Contact Information: China Ceramics Co., Ltd. Precept Investor Relations LLC Edmund Hen, Chief Financial Officer David Rudnick, Account Manager Email: info@cceramics.com Email: david.rudnick@preceptir.com Phone: +1 917-864-8849 China Ceramics Announces First Quarter 2016 Financial Results Jinjiang, Fujian Province, China, June 2, 2016 First Quarter 2016 Highlights § Revenue was RMB 134.2 million (US$ 20.8 million), down 36.0% from the first quarter] []

By | 2016-06-04T03:04:55+00:00 June 3rd, 2016|Categories: CCCL, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

CCCL [China Ceramics] 6-K: Contact Information: China Ceramics Co., Ltd. Precept Investor

[Contact Information: China Ceramics Co., Ltd. Precept Investor Relations LLC Edmund Hen, Chief Financial Officer David Rudnick, Account Manager Email: info@cceramics.com Email: david.rudnick@preceptir.com Phone: +1 917-864-8849 China Ceramics Announces First Quarter 2016 Financial Results Jinjiang, Fujian Province, China, June 2, 2016 First Quarter 2016 Highlights § Revenue was RMB 134.2 million (US$ 20.8 million), down 36.0% from the first quarter] []

By | 2016-06-04T03:05:59+00:00 June 3rd, 2016|Categories: CCCL, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] SC 13D/A: (Original Filing)

[Execution Version CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT June 2, 2016 June 2, 2016 Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA United Kingdom Schedule I As the Sole Underwriter named in Ladies and Gentlemen: Selling Stockholders Company Schedule II Schedule I Underwriter Shares] [CUSIP No. 16938C106 1. Names of reporting persons. WP X Biologics LLC 2. Check the appropriate box if a member of a group (see instructions). ¨ x (a) 3. SEC use only 4. Source of funds (see instructions) N/A 5. ¨]

By | 2016-06-04T03:13:53+00:00 June 3rd, 2016|Categories: CBPO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] SC 13D/A: Execution Version CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES

[Execution Version CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT June 2, 2016 June 2, 2016 Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA United Kingdom Schedule I As the Sole Underwriter named in Ladies and Gentlemen: Selling Stockholders Company Schedule II Schedule I Underwriter Shares] [CUSIP No. 16938C106 1. Names of reporting persons. WP X Biologics LLC 2. Check the appropriate box if a member of a group (see instructions). ¨ x (a) 3. SEC use only 4. Source of funds (see instructions) N/A 5. ¨]

By | 2016-06-04T03:14:41+00:00 June 3rd, 2016|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar